Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Pancreatic cancer is a malignant disease arising from pancreatic cells and remains a major global health burden. According to Freddie Bray et al. (2024), approximately 511,000 new cases and 467,000 deaths occurred worldwide in 2022, accounting for almost 5% of global cancer deaths. According to the pancreatic cancer epidemiology forecast by Expert Market Research, its burden remains significant.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Pancreatic Cancer – Number of Cases by Year

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Pancreatic Cancer Epidemiology Forecast Report Coverage

Expert Market Research's “Pancreatic Cancer Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of pancreatic cancer. It projects the future incidence and prevalence rates of pancreatic cancer cases across various populations. The study covers age, gender, and type as major determinants of the pancreatic cancer population. The report highlights patterns in the prevalence of pancreatic cancer over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of pancreatic cancer in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Pancreatic Cancer Understanding: Disease Overview

Pancreatic cancer is a malignant disease that develops when abnormal cells in the pancreas grow uncontrollably and form tumors. It most commonly originates in the exocrine cells, particularly the ducts, and is therefore predominantly classified as pancreatic ductal adenocarcinoma. Less common types include pancreatic neuroendocrine tumors, which arise from hormone-producing cells. Risk factors include increasing age, cigarette smoking, obesity, chronic pancreatitis, diabetes, and certain inherited genetic syndromes. Because early disease may cause few or nonspecific symptoms, pancreatic adenocarcinoma is frequently diagnosed at an advanced stage.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Country

India

High-Risk Population

Older adults, smokers, and individuals with chronic pancreatitis or a family history of pancreatic cancer

Key Diagnostic Method

Contrast-enhanced computed tomography (CT)

Major Risk Factor

Cigarette smoking

Major gap in the market

Late diagnosis and limited detection of early-stage disease

Pancreatic Cancer Epidemiology Perspective

The pancreatic cancer epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the pancreatic cancer epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pancreatic cancer and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to Freddie Bray et al. (2024), there were approximately 511,000 new cases of pancreatic cancer globally in 2022. Pancreatic cancer incidence is particularly high in Europe, North America, and Australia/New Zealand, while rates are approximately four times higher in countries with higher versus lower Human Development Index levels.

Gender-Specific Cases of the Disease

According to Xiao Li et al. (2025), 273,617 of 508,532 global incident cases in 2021 were among males, representing 53.8% of cases. Kun Huang et al. (2025) similarly reported higher global pancreatic cancer prevalence and incidence among males, particularly at older ages.

Age-Specific Cases of the Disease

As per Kun Huang et al. (2025), pancreatic cancer prevalence and incidence increase with age, with incidence increasing sharply after age 65 and reaching the highest rates among individuals older than 75 years. According to Xiao Li et al. (2025), incident cases and deaths peaked at ages 70–74 years.

Ethnicity-Wise Cases of the Disease

Pancreatic cancer prevalence and incidence can vary across ethnic populations because of differences in genetic susceptibility, demographic characteristics, lifestyle patterns, obesity, diabetes, smoking, alcohol consumption, and access to healthcare services. Differences in screening, diagnosis, and healthcare utilization may also influence observed disease burden across populations.

Mortality and Survival Analysis of the Disease

According to Freddie Bray et al. (2024), pancreatic cancer caused approximately 467,000 deaths globally in 2022, accounting for almost 5% of all cancer deaths worldwide. Xiao Li et al. (2025) reported 505,752 deaths in 2021, while the five-year relative survival rate in the United States remains 13%.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Exocrine Tumors

Exocrine tumors account for major share of pancreatic cancer cases and include pancreatic ductal adenocarcinoma, acinar cell carcinoma, adenosquamous carcinoma, and colloid carcinoma.

Neuroendocrine Tumors / PNETs

Neuroendocrine tumors account for lesser share of pancreatic cancer cases and originate from hormone-producing islet cells of the pancreas.

Pancreatic Cancer – Number of Cases by Country

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Country-wise Pancreatic Cancer Epidemiology

The Pancreatic Cancer epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to American Cancer Society (2026), approximately 67,530 people are estimated to be diagnosed with pancreatic cancer in the United States in 2026, including 35,190 men and 32,340 women. Approximately 52,740 deaths are projected, including 27,230 men and 25,510 women. The average lifetime risk is approximately 1 in 56 for men and 1 in 60 for women. According to The Pancreatic Cancer Action Network (2026), the five-year relative survival rate remains 13%.

Germany

According to Marko Damm et al. (2025), the lifetime risk of developing pancreatic cancer in Germany is approximately 1.9%. The incidence of pancreatic cancer is expected to continue increasing in Western countries, contributing to its growing epidemiological and mortality burden.

France

The pancreatic cancer burden in France is influenced by an aging population and established risk factors such as smoking, obesity, diabetes, and heavy alcohol consumption. Increasing life expectancy may contribute to the number of cases because pancreatic cancer occurs predominantly at older ages. Changes in population-level exposure to modifiable risk factors, together with improvements in cancer detection and diagnosis, can also influence observed incidence and prevalence.

Italy

According to OECD, between 2012 and 2020, Italy's premature years of potential life lost rate from pancreatic cancer increased by 4%. Pancreatic cancer was the only high-incidence cancer site in the assessment that had not recorded a decline in mortality during the preceding decade. A slight increase in incidence was also reported among Italians aged 50–69 years.

Spain

According to Centro Nacional de Investigaciones Oncológicas, more than 10,300 pancreatic cancer cases are diagnosed annually in Spain. The five-year survival rate after diagnosis is less than 10%, indicating a substantial mortality burden associated with pancreatic cancer in the country.

United Kingdom

According to Birmingham HPB Clinic, pancreatic cancer accounts for approximately 3% of all cancers in the United Kingdom but approximately 7% of cancer-related deaths. The risk increases with age, with most pancreatic cancer cases occurring among people older than 60 years.

Japan

According to Servier, Japan reported 47,627 new pancreatic cancer cases and 43,265 deaths in 2022. Pancreatic cancer was the fourth leading cause of cancer death in Japan. Diagnosed cases are projected to increase at an annual growth rate of 1.50%, with population aging and changes in dietary habits identified as contributing factors.

India

According to Mohd Haris Jamal et al. (2025), pancreatic cancer has an annual incidence of approximately 10,860 new cases in India, representing 1.03% of all malignancies. The number of cases was reported to increase from 10,969 in 2015 to 11,655 in 2020. Mizoram had the highest age-adjusted incidence rates, while the northeastern region had the largest overall number of cases.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The regional pancreatic cancer landscape faces substantial unmet needs because symptoms are often nonspecific and there is no recommended population-wide screening strategy for individuals at average risk. Consequently, many patients are diagnosed after the disease has become locally advanced or metastatic, limiting curative treatment options. Opportunities exist to improve risk-based surveillance for high-risk populations, strengthen access to specialized diagnostic imaging and molecular testing, and accelerate biomarker-based detection approaches. Expanding access to multidisciplinary pancreatic cancer care and precision treatment could further address disparities across the United States, European countries, Japan, India, and the United Kingdom.

Pancreatic Cancer: Treatment Overview

Pancreatic cancer treatment depends on tumor location, disease stage, resectability, overall health, and whether the cancer has spread. Surgical resection, including the Whipple procedure, distal pancreatectomy, or total pancreatectomy, may provide potentially curative treatment for selected patients with localized disease. Systemic chemotherapy is commonly used for resectable, borderline resectable, locally advanced, and metastatic disease. Radiation therapy may be used in selected settings, particularly for locally advanced tumors. Targeted therapy and immunotherapy may benefit patients with specific molecular alterations or biomarkers. Systemic anticancer therapy therefore remains an important component of treatment.

Key Questions Answered

  • What is the current and projected burden of pancreatic cancer across the 8 major markets?
  • Which countries across the 8 major markets account for the highest pancreatic cancer patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of pancreatic cancer across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of pancreatic cancer across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of pancreatic cancer across the 8 major markets?
  • How do major comorbidities and risk factors influence pancreatic cancer epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of pancreatic cancer across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the pancreatic cancer landscape across the 8 major markets?
  • Which therapeutic areas linked to pancreatic cancer are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the pancreatic cancer epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on pancreatic cancer epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for pancreatic cancer across the 8 major markets?

Scope of the Pancreatic Cancer Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pancreatic cancer based on several factors.
  • Pancreatic Cancer Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The pancreatic cancer report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Pancreatic Cancer Pipeline Analysis Report

Advanced Pancreatic Cancer Pipeline Analysis Report

Metastatic Pancreatic Cancer Pipeline Analysis Report

Advanced Pancreatic Cancer Epidemiology Forecast

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us